Tools

Denmark’s Novo Nordisk, the world’s biggest insulin producer, will sell its long-acting insulin Tresiba in Europe at a 60-70 percent… »   

U.S. regulators gave priority review status to an experimental GlaxoSmithKline drug for HIV/AIDS, which industry analysts view as a possible… »   

The U.S. Food and Drug Administration has approved the first artificial retina, an implanted device that replicates some of the… »   

U.S. regulators gave priority review status to an experimental GlaxoSmithKline drug for HIV/AIDS, which industry analysts view as a possible… »   

An Indiana company has won temporary court relief from having to provide its employees with coverage for contraceptives and other… »   

For pharmaceutical companies, Africa is changing.

Not only is the continent’s economic growth grabbing attention in boardrooms but the shifting… »   

Irish drugmaker Elan is raising more than $3.25 billion by selling its interests in its main drug and will splash… »   

GlaxoSmithKline plans to cut costs in its struggling European drugs division and promised investors a return to growth this year,… »   

Biogen Idec Inc’s agreement to buy Elan Corp Plc’s interest in the multiple sclerosis drug Tysabri gives Biogen full control… »   

When it comes to gene sequencing and personalized medicine for cancer, spotting an aberrant kinase is a home run. The… »